The last year has seen a number of advances in treatment and medications. Stribild, a once-daily, single-pill regimen, and Tivicay, a newly approved integrase inhibitor, are now on the list of "preferred" HIV medications in the official U.S. HIV treatment guidelines -- a recommendation that was announced on Oct. 30. Until that date, only four medications were recommended for first-line treatment: Atripla, Norvir/Reyataz/Truvada, Norvir/Prezista/Truvada and Isentress/Truvada. The changes highlight "the rise of integrase inhibitors as an established, reliable family" of medications for first-line treatment, in the words of TheBody.com's Myles Helfand in a recent piece.
Also making news: On Dec. 31, 2012, the Food and Drug Administration approved Fulyzaq (crofelemer) as the first drug to relieve symptoms of diarrhea that is a side effect of HIV antiretrovirals. Current HIV medications are "aren't nearly as likely to cause diarrhea as the first generation of meds did -- but it remains a problem for many.
Rod McCullom has written and produced for ABC News, NBC and FOX, The Atlantic, the Los Angeles Times, EBONY, POZ and many others. Read his blog at Rod 2.0.
(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Before adding your comment, please read TheBody.com's Comment Policy.)
The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.